Oral vinorelbine: a narrative review
Intended for healthcare professionals
Evidence & Practice Previous     Next

Oral vinorelbine: a narrative review

Carole Farrell Research fellow, The Christie Hospital NHS Foundation Trust, Manchester, England
Victoria Harmer Macmillan consultant nurse (breast), Imperial College London, England
Mark Foulkes Nurse consultant/lead cancer nurse, Royal Berkshire NHS Foundation Trust, Reading, England
Tom Allum Macmillan patient information and support service manager, Imperial College London, England

The incidence of many cancers is increasing; coupled with a decline in mortality rates (Cancer Research UK 2017a) this translates to more people living with and beyond their cancer diagnosis. Cancer is generally viewed as a chronic condition and this is often true for many diagnosed with metastatic breast cancer (MBC). In advanced/metastatic disease, there is a greater emphasis on promoting patients’ quality of life, and oral treatments can have additional benefits for patients, such as ease of administration, potentially reduced toxicities and fewer hospital visits. Oral vinorelbine was licenced in 2006 for the treatment of non-small cell lung cancer and MBC. This paper provides a narrative review of evidence from clinical trials, outlining the development and clinical application of oral vinorelbine, including implications for clinical practice and patient care.

Cancer Nursing Practice. 17, 2, 25-33. doi: 10.7748/cnp.2018.e1468



Conflict of interest

None declared

Peer review

This article has been subject to external double-blind review and has been checked for plagiarism using automated software

Write for us

For information about writing for RCNi journals, contact writeforus@rcni.com

For author guidelines, go to rcni.com/writeforus

Received: 14 July 2017

Accepted: 11 January 2018

Want to read more?

Already have access? Log in


3-month trial offer for £5.25/month

Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
  • Unlimited access to all 10 RCNi Journals
  • RCNi Learning featuring over 175 modules to easily earn CPD time
  • NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
  • Personalised newsletters tailored to your interests
  • A customisable dashboard with over 200 topics

Alternatively, you can purchase access to this article for the next seven days. Buy now

Are you a student? Our student subscription has content especially for you.
Find out more